Physician

Michael P Eyre

According to 2025 Medicare claims, Michael Eyre (NPI: 1063481646) practices dermatology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is ASPEN DERMATOLOGY PLLC (NPI: 1407917107; TIN: 204009858) and primary practice location at 84651-1932. Eyre is affiliated with the Aledade 201 National MSSP (ACO ID: A5522), participating under the MSSP model.

Eyre's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 584 traditional Medicare patients, billed 5,981 HCPCS/CPT codes, and received $381,297 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 537 prescription claims across 246 beneficiaries totaling $182,385 in drug costs, led by Cosentyx Unoready Pen (Secukinumab). Open Payments data shows 83 records totaling $1,593. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $290,311 to $381,297. Similarly, Part D prescription costs have risen steadily, from $29,636 to $182,385. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$246K$491K2015 Medicare payment: $290,311 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $283,898 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $264,220 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $325,272 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $424,253 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $403,045 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $387,523 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $466,175 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $491,009 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $381,297 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156805,191$290,311
20166785,664$283,898
20177075,619$264,220
20186926,773$325,272
20197577,997$424,253
20207157,956$403,045
20217016,902$387,523
20226777,009$466,175
20236257,442$491,009
20245845,981$381,297

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$118K$236K2015 Drug cost: $29,636 (USD; Tot_Drug_Cst)2016 Drug cost: $25,919 (USD; Tot_Drug_Cst)2017 Drug cost: $22,433 (USD; Tot_Drug_Cst)2018 Drug cost: $26,856 (USD; Tot_Drug_Cst)2019 Drug cost: $236,062 (USD; Tot_Drug_Cst)2020 Drug cost: $32,541 (USD; Tot_Drug_Cst)2021 Drug cost: $43,272 (USD; Tot_Drug_Cst)2022 Drug cost: $59,278 (USD; Tot_Drug_Cst)2023 Drug cost: $153,909 (USD; Tot_Drug_Cst)2024 Drug cost: $182,385 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015182352$29,636
2016190360$25,919
2017210400$22,433
2018173295$26,856
2019201415$236,062
2020215428$32,541
2021203396$43,272
2022207426$59,278
2023210443$153,909
2024246537$182,385

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks114156$445
11102Biopsy of related skin growth, first growth173209$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more371653$60
17000Destruction of precancer skin growth, 1 growth369518$39
17003Destruction of precancer skin growth, 2-14 growths3322,469$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Unoready PenSecukinumab11308$120,164
Betamethasone DipropionateBetamethasone Dipropionate661,626$2,851
Clobetasol PropionateClobetasol Propionate671,792$2,358
Doxycycline HyclateDoxycycline Hyclate381,180$1,255
DapsoneDapsone12688$1,117

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.83$1,593ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael P. Eyre?

Tedicare shows public-source Medicare data for Michael P. Eyre (NPI 1063481646), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael P. Eyre have ACO affiliation data?

Michael P. Eyre is shown with ACO affiliation data for Aledade 201 National MSSP (MSSP, ACO ID A5522).

What billing organization is linked to Michael P. Eyre?

Michael P. Eyre is linked to ASPEN DERMATOLOGY PLLC (billing NPI 1407917107) in the available physician profile data.

Does Michael P. Eyre have Open Payments data?

Michael P. Eyre has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.